iClinic Competitive Intelligence & Landscape
iclinic.com.br ·
Overview
iClinic Overview
The company's services target a broad market, including patients in rural and underserved areas, as well as international markets like Africa and India. iClinic's business models include assisted remote consultations, where local doctors assist patients in connecting with specialists, and a web-based portal for 24/7 online doctor consultations, second opinions, and online advice (Exa). With over 55 specialists and partnerships with major hospital chains such as Max, Fortis, and Medica, iClinic aims to enhance healthcare accessibility and efficiency.
As of 2026, iClinic remains a private company with a small but growing team of around 6 employees, and it has established itself as a key player in the digital health space, emphasizing innovative telehealth solutions and ecosystem integration. Its mission is to improve healthcare access and quality through technology, making healthcare more accessible, efficient, and patient-centric (Exa).
Sources
icliniccare.com
iClinic - Company Profile
tracxn.com
iClinic - 2025 Company Profile, Team & Competitors - Tracxn
tracxn.com
MDLand - Health Care Company Profile, Funding & Investors - BounceWatch
bouncewatch.com
MDLand - Health Care Company Profile, Funding & Investors - Bounce Watch
bouncewatch.com
MDLand Company Overview, Contact Details & Competitors | LeadIQ
leadiq.com
Access Insights for Millions of Other Companies
leadiq.com
iClinic Healthcare Private Limited
in.linkedin.com
iClinic Weekly Intel Updates
Receive weekly intel updates about iClinic straight to your inbox.
Competitors
iClinic Competitors
ClinicSource is another notable competitor, primarily targeting outpatient clinics and offering robust scheduling, billing, and EHR functionalities. It scores higher in overall performance (8.2 vs. iClinic's 6.6), but iClinic's competitive edge lies in its user-friendly interface and tailored solutions for small practices, often at a lower price point (financesonline.com).
PracticeAdmin is a practice management software that closely rivals iClinic, with a slightly higher overall score (6.9 vs. 6.6). It offers extensive features for billing and scheduling but may lack some of the integrated patient engagement tools that iClinic provides. iClinic's market share is growing due to its simplicity and targeted approach for small practices, making it a popular choice among emerging healthcare providers (financesonline.com).
Finally, Oracle Cerner stands out as a major competitor in the broader EMR market, especially for large healthcare organizations. It offers extensive customization and scalability but is often more expensive and complex, making it less suitable for small practices compared to iClinic’s streamlined solutions (technologycounter.com)).
Sources
Top 10 Cerner Competitors for Practices (2026) - Software Finder
softwarefinder.com
iClinic vs ClinicSource 2026 Comparison | FinancesOnline
comparisons.financesonline.com
iClinic Alternatives & Competitors
technologycounter.com
iClinic vs PracticeAdmin 2026 Comparison | FinancesOnline
comparisons.financesonline.com
iClinics Alternatives & Competitors
technologycounter.com
Product & Pricing
iClinic Product and Pricing Intelligence
The available tiers include a basic Starter plan at around $99 per month per provider, a Plus plan at approximately $129, a Pro plan at $169, and a Premium plan at $299, with the latter offering more advanced features and integrations. These plans include core functionalities such as appointment scheduling, electronic prescriptions, clinical documentation, patient portals, telemedicine, and compliance tracking. The platform also supports integration with third-party labs and diagnostic services, enhancing its utility for diverse healthcare settings (iClinic Preços, TechnologyCounter).
Recent updates emphasize increased flexibility, with the ability to choose between monthly and yearly billing cycles, and the platform's cloud-based nature ensures accessibility across devices, including mobile browsers. Pricing details and tiers are subject to change, and potential users are encouraged to contact iClinic directly for personalized quotes and the latest pricing options (SoftwareFinder, SaaSCounter).
Sources
iClinic Reviews, Pricing & Free Demo - Software Finder - 2026
softwarefinder.com
iClinic: Reviews, Pricing & Free Demo - FindEMR
findemr.com
iClinic EMR Pricing, Features & More 2026 | SaaSCounter
saascounter.com
iClinic | Pricing, Features & Reviews
technologycounter.com
Planos e preços - iClinic Software Médico
iclinic.com.br
Patient Data Lost in Ransomware Attack on EHR Vendor
hipaajournal.com
Electronic Billing & Practice Management - MDLand
mdland.com
iClinic vs Luminello 2025 Comparison | FinancesOnline
comparisons.financesonline.com
Ad Campaigns
iClinic Ad Campaigns
iClinic is currently running 400 ads across Google — 400 on Google. Explore iClinic's live ad creative, messaging, and the platforms they advertise on in the ad library — updated automatically by ForesightIQ.
See of iClinic's ads
Browse the live creative across Google, Meta & LinkedIn in the ad library
Hiring & Layoffs
iClinic Hiring and Layoffs
Recent hiring trends indicate that iClinic is actively recruiting, likely to support its ongoing product development and market expansion efforts within Brazil and potentially beyond. The company's strategy appears to emphasize growth in healthcare technology, leveraging its strong position in the Brazilian medical software market, which is reflected in its continued investment in talent acquisition (iCIMS).
There are no publicly available reports of layoffs at iClinic in early 2026, which suggests that the company is focused on strengthening its workforce to meet increasing demand for healthcare digital solutions. This hiring pattern signals a strategic emphasis on innovation, customer service, and expanding its product offerings, rather than restructuring or downsizing, indicating a positive outlook for its growth trajectory in the healthcare tech sector.
Sources
Where is iClinic Located? HQ, Global Offices & Company Insights
highperformr.ai
Healthcare Hiring Shows Early 2026 Momentum Amid Growing ...
prnewswire.com
ResearchAyu - Lead - Talent Acquisition
iimjobs.com
MDLand - Health Care Company Profile, Funding & Investors - BounceWatch
bouncewatch.com
iClinica
de.linkedin.com
Leadership
iClinic Management and Leadership Team
In addition to the leadership team, iClinic is a Brazilian healthcare software company acquired by Afya Limited in 2020, which has contributed to its growth and expansion. The company was founded in 2012 and has grown significantly, with notable leadership including founders and executive team members involved in product development and strategic growth (rockstart.pr.co). The company’s headquarters are located in São Carlos, Brazil, and it continues to focus on innovation in medical practice management software (highperformr.ai). Overall, iClinic’s leadership combines experienced healthcare executives and technology professionals to drive its strategic initiatives.
Sources
Senior Leadership | The Iowa Clinic
iowaclinic.com
Where is iClinic Located? HQ, Global Offices & Company Insights
highperformr.ai
Rockstart’s portfolio company iClinic acquired by Afya Limited for €27.9m | Rockstart Newsroom
rockstart.pr.co
Governance & Leadership - Cleveland Clinic
my.clevelandclinic.org
Executive Management - Mediclinic Group
mediclinic.com
Leadership | Cleveland Clinic
my.clevelandclinic.org
The Guthrie Clinic Leadership Team/Board of Directors
guthrie.org
iClinic - Company Profile
tracxn.com
Financials
iClinic Financial Performance, Fundraising, M&A
In terms of funding and valuation, specific details about recent funding rounds or current valuation are not explicitly available in the search results. However, iClinic was acquired by Afya Limited in January 2021, which marked a significant milestone in its financial history. This acquisition, valued at a strategic level, positioned iClinic as a leading medical practice management software provider in Brazil, with Afya aiming to leverage its SaaS platform to expand its healthcare services (markets.businessinsider.com).
Regarding M&A activity, the acquisition by Afya Limited is the most prominent recent transaction involving iClinic, highlighting its value and strategic importance within the healthcare technology sector. The deal was finalized in early 2021, and since then, iClinic has continued to operate as part of Afya’s broader digital health strategy, focusing on improving healthcare delivery through its cloud-based solutions (markets.businessinsider.com).
Sources
Afya Limited Announces Closing of the Acquisition of iClinic
markets.businessinsider.com
iClinic Reviews - Pros, Cons, and Features - 2026 - Software Finder
softwarefinder.com
Performance Reports: A Critical Clinic Management System Feature
clinictracker.com
iClinic - Company Profile
tracxn.com
iClinic Revenue and Competitors
growjo.com
Where is iClinic Located? HQ, Global Offices & Company Insights
highperformr.ai
Partnerships
iClinic Partnerships, Clients and Vendors
In terms of enterprise clients and ecosystem relationships, iClinic caters to large physician organizations through its iClinic Enterprise solution, launched in late 2023, which is tailored for Managed Service Organizations (MSOs), Accountable Care Organizations (ACOs), and large physician groups. This enterprise-level platform emphasizes interoperability, compliance, and workflow efficiency, supporting complex healthcare networks (mdland.com).
Furthermore, iClinic integrates with several third-party applications such as Solstas Labs, LabCorp, and Quest Diagnostics, broadening its ecosystem and enhancing its capability to manage lab orders, imaging, billing, and patient engagement. The company's ecosystem relationships are designed to improve clinical data exchange, streamline practice management, and support quality-driven care (info.mdland.com).
Sources
Lab Interfacing - MDLand | Developed by physicians for physicians
mdland.com
iClinic EHR developed by physicians for physicians - MDLand
info.mdland.com
MDLand Launches iClinic® Enterprise: A Comprehensive EHR ...
mdland.com
Electronic Billing & Practice Management - MDLand
mdland.com
iClinic Reviews - Pros, Cons, and Features - 2026 - Software Finder
softwarefinder.com
iClinic: Reviews, Pricing & Free Demo - FindEMR
findemr.com
Exciting new partnership with AiCure | IMA Research
imaresearch.com
Compare iClinic vs NueMD 2026 | FinancesOnline
comparisons.financesonline.com
Events
iClinic Event Participations
Additionally, iClinic organizes webinars on topics like Google My Business optimization for clinics, aimed at helping healthcare providers improve their online visibility and attract more patients, demonstrating their focus on digital marketing strategies (iClinic). They also sponsor and promote events related to healthcare technology, such as the Real-World Evidence Summit 2025 organized by ISPOR, which explores connecting clinical trials to real-world data, indicating their interest in cutting-edge research and evidence-based practices (ISPOR).
While specific details about all their event participations are not exhaustively listed, it is clear that iClinic is actively involved in educational webinars, industry conferences, and community engagement initiatives to foster innovation in healthcare technology and digital health solutions.
Sources
Telemedicina: da norma à prática na dermatologia
content.iclinic.com.br
Google Meu Negócio para Médicos: Checklist Prático 2026
content.iclinic.com.br
Sharing Your Medical Record - MyChart
mychart.org
Participant Audit Log - OpenClinica Reference Guide
docs.openclinica.com
Using event logs to observe interactions with electronic health records
academic.oup.com
Digital Health Solutions - MDLand
mdland.net
ISPOR - Beyond the Boundaries of RCT Data: Connecting Trials to the Real-World
ispor.org
Frequently Asked Questions
What does iClinic's acquisition by Afya Limited signal about its strategic trajectory, and is it operating independently or being absorbed?
iClinic was acquired by Afya Limited in January 2021 for approximately $27.9 million, positioning it as a core asset within Afya's broader digital health strategy in Brazil. Since the acquisition, iClinic has continued to operate as a distinct SaaS platform focused on medical practice management rather than being dissolved into a generic product line. This suggests Afya is using iClinic as a beachhead in the clinical software layer, leveraging its ~$18.6 million in estimated annual revenue and ~128-person team to expand Afya's footprint beyond medical education into practice operations.
What does iClinic's hiring pattern as of early 2026 suggest about its near-term product or market priorities?
As of March 2026, iClinic shows no layoffs and is actively recruiting, with a notable year-over-year employee count growth reported. The hiring focus appears concentrated in healthcare technology and software development, signaling continued investment in product capability rather than a cost-reduction or consolidation phase. Within the context of its Afya ownership, this pattern is consistent with a mandate to build out the platform — likely in areas such as telemedicine infrastructure, interoperability, and enterprise features — rather than harvest the asset.
Is iClinic's estimated $18.6 million annual revenue figure a turnaround story or a plateau risk inside a larger parent?
At roughly $18.6 million in estimated annual revenue with approximately 128 employees, iClinic generates revenue per employee consistent with a maturing SaaS business rather than a high-growth startup. The absence of disclosed post-acquisition funding rounds or standalone valuation updates makes it difficult to confirm accelerating growth, and the signal is ambiguous — it could reflect steady organic expansion within Afya's ecosystem or a business that has stabilized post-acquisition. Corp-dev teams should treat this revenue figure as a baseline and probe Afya's quarterly filings for iClinic-specific cohort data before drawing conclusions.
What does iClinic's tiered pricing structure reveal about which customer segments it is prioritizing?
iClinic's pricing ladder — Starter at ~$99/month per provider, Plus at ~$129, Pro at ~$169, and Premium at ~$299 — is calibrated for small to medium-sized individual and group practices rather than large hospital systems. The premium tier's advanced integrations and the launch of an enterprise solution for MSOs and ACOs in late 2023 indicate a deliberate upmarket move, attempting to layer higher-ACV contracts onto a base of SMB clinics. This dual-market strategy introduces execution risk but signals that iClinic is attempting to expand average contract value without abandoning its core SMB install base.
What does iClinic's iClinic Enterprise launch in late 2023 signal about competitive repositioning?
The launch of iClinic Enterprise in late 2023, targeting Managed Service Organizations, Accountable Care Organizations, and large physician groups, marks a clear strategic move upmarket into territory traditionally owned by larger EMR vendors. The product emphasizes interoperability, compliance, and multi-site workflow management — capabilities that are table stakes for enterprise healthcare buyers. This repositioning, under Afya's ownership, suggests iClinic is being used to compete for larger contracts that Afya's medical education platform alone could not capture, potentially setting up iClinic as the clinical operations layer in a vertically integrated Afya stack.
What do iClinic's event and webinar activities — including telemedicine and Google My Business topics — reveal about its go-to-market approach?
iClinic's webinar portfolio spans clinical topics like secure telemedicine implementation and practical digital-marketing topics like Google My Business optimization for clinics. This dual focus reveals a go-to-market model that positions iClinic as a practice-growth partner, not merely a software vendor — an approach designed to deepen stickiness with small practice owners who wear both clinical and administrative hats. It also signals that iClinic's primary buyer persona is the practice owner or office manager rather than an enterprise IT department, which is consistent with its SMB-oriented pricing tiers.
How does iClinic's competitive positioning against Cerner and Oracle Cerner hold up, and where is it genuinely differentiated?
iClinic competes with Cerner and Oracle Cerner primarily by avoiding direct head-to-head confrontation: both enterprise platforms are built for large hospital systems and carry complexity and cost that make them impractical for small Brazilian practices. iClinic's differentiation lies in affordability, ease of use, and a Brazilian-market-specific product fit, and it scores 100% user satisfaction in at least one benchmark comparison, though its overall platform score of 6.6 trails ClinicSource (8.2) and PracticeAdmin (6.9). The real competitive risk for iClinic is not Cerner but domestic Brazilian SaaS competitors that can match its price and local focus.
What does iClinic's partnership with diagnostic labs like Quest Diagnostics and BioReference signal about its interoperability strategy?
iClinic's integrations with Quest Diagnostics, BioReference Laboratories, Solstas Labs, and Accurate Diagnostics — along with a free Cologuard® offering — indicate a deliberate strategy to become the interoperability hub for ambulatory practices rather than a standalone EHR. By embedding lab ordering and results exchange directly into clinical workflows, iClinic reduces the friction that typically drives practice switching decisions. For a platform targeting SMB clinics that lack dedicated IT staff, pre-built lab integrations are a meaningful retention mechanism and a barrier to displacement by competing systems.
Is the leadership structure at iClinic stable enough to execute on its upmarket enterprise push, and are there visible succession risks?
Publicly available leadership data for iClinic's Brazilian operations is thin; the most detailed executive roster in available sources references an Iowa-based clinic's leadership team, which appears to be a data conflation. What is confirmed is that iClinic was founded in 2012, was acquired by Afya in 2021, and the company's São Carlos-based team continues to operate. The absence of disclosed C-suite changes post-acquisition could indicate stability or limited transparency — either way, corp-dev analysts should verify whether iClinic's product and go-to-market leadership sits inside Afya's executive structure or remains an autonomous unit.
What does iClinic's participation in the Real-World Evidence Summit 2025 signal about future product directions?
iClinic's association with the ISPOR Real-World Evidence Summit 2025 — an event focused on connecting clinical trial data with real-world outcomes — suggests the company is exploring or positioning for capabilities beyond practice management, potentially in clinical data aggregation, outcomes tracking, or pharma-facing analytics. For a practice management SaaS with a large Brazilian clinic install base, the underlying patient data asset has obvious value in real-world evidence contexts. Whether this reflects an active product roadmap initiative or opportunistic brand positioning is unclear from available data, but ForesightIQ tracks event participation as an early signal of strategic intent.
How exposed is iClinic to displacement by AdvancedMD, Practice Fusion, or other cloud-based alternatives given its current feature set?
iClinic's primary alternative threat in the cloud-EHR space comes from platforms like AdvancedMD and Practice Fusion, which offer comparable scheduling, billing, telehealth, and patient engagement features — often with more mature U.S.-market track records. However, iClinic's key moat in Brazil is local market fit: regulatory compliance with Brazilian healthcare requirements, Portuguese-language support, and domestic lab integrations create switching costs that U.S.-origin platforms struggle to replicate quickly. The more credible displacement risk comes from Brazilian-native competitors with similar local advantages rather than internationally oriented platforms.
What does the combination of Afya's ownership, iClinic's SMB install base, and its enterprise product launch suggest about a potential exit or secondary transaction scenario?
Afya's acquisition of iClinic for ~$27.9 million in 2021 was framed as a strategic move to extend beyond medical education into clinical software. With estimated annual revenue now at ~$18.6 million and a growing team of ~128, iClinic's revenue multiple at acquisition appears modest, and Afya has had time to expand the platform. The late-2023 enterprise launch targeting MSOs and ACOs is the kind of product investment that precedes either a significant upsell cycle that improves unit economics for Afya or positions the asset for a secondary transaction at a higher multiple — particularly attractive to strategic buyers seeking a foothold in Brazil's digital health infrastructure.
Powered by ForesightIQ · Competitive intelligence from digital exhaust